Page last updated: 2024-10-30

beta-lapachone and Glial Cell Tumors

beta-lapachone has been researched along with Glial Cell Tumors in 2 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, EJ1
Choi, KS1
Kwon, TK1
Weller, M1
Winter, S1
Schmidt, C1
Esser, P1
Fontana, A1
Dichgans, J1
Groscurth, P1

Other Studies

2 other studies available for beta-lapachone and Glial Cell Tumors

ArticleYear
β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells.
    Chemico-biological interactions, 2011, Jan-15, Volume: 189, Issue:1-2

    Topics: Adenine; Autophagy; Blotting, Western; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Flow Cyto

2011
Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.
    International journal of cancer, 1997, Nov-27, Volume: 73, Issue:5

    Topics: Apoptosis; bcl-2-Associated X Protein; Camptothecin; Cell Cycle Proteins; Cell Division; Cell Surviv

1997